<p>This episode is brought to you by the <a href="https://shop.theprimal.com/" target="_blank" rel="ugc noopener noreferrer">Primal Tallow Balms</a>.</p><p><br></p><p><strong>Dr. Andrew Koutnik</strong> is a metabolic scientist who has completed a study on a high-fat ketogenic diet over a 10-year period in a high-risk patient population (type 1 diabetes). This patient population has a <strong>10x higher cardiovascular risk</strong> compared to non-diabetics.</p><p>The question proposed in this 10-year-long high-fat, low-carb study was to assess end markers including <strong>glycemic control</strong> and <strong>advanced cardiovascular markers</strong>, while keeping other variables consistent. The results were surprising, showing notable outcomes in both <strong>glycemic control</strong> and <strong>LDL cholesterol</strong>.</p>